Gyrolab Generic Anti-AAV Kit supports gene therapy development
Ready-to-use kit from Gyros Protein Technologies enables the detection of binding antibodies against AAV vectors without the need for serotype-specific assays
Ready-to-use kit from Gyros Protein Technologies enables the detection of binding antibodies against AAV vectors without the need for serotype-specific assays
Explore the modern point-of-care ecosystem and its impact on healthcare delivery
Learn about clinical aspects of Graves’ Disease and the use of TSH immunoglobulin assay for diagnosis and monitoring
Learn why antibodies are excellent clinical biomarkers – and the key technology you need to profile them
This research project promises to reduce the costs of cell and gene therapy manufacturing processes, making therapies more accessible and cost-effective
This guest editorial explores how regenerative agriculture can solve current farming challenges, and how soil health may be the answer under our feet
Used by laboratories carrying out nucleic acid-based testing, PrimeStore MTM ensures the transport and testing process is streamlined and safe
Learn about the different types of battery testing and explore additional considerations for optimizing performance
In a guest editorial from H.E.L Group, explore how pressurized bioreactors and synthetic biology can mitigate the dangerous effects of climate change
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare
Learn how the latest automated cell counting technology is enhancing autoimmune disease research at Yale School of Medicine’s Hafler Lab
The new Valita Aggregation Pure assay can provide aggregation data in just 15 minutes
Aiding in the fight against species extinction and biodiversity loss
The UK’s largest lab industry event set to break more records as it returns this autumn
Automated protocols now available for mRNA and DNA sequencing
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
The RX Series expands the capability and productivity of triple quadrupole mass spectrometry
Latest mass spectrometry innovations showcased at the this year's annual conference
Setting new standards for delivering high-resolution and speed, critical for large population and epidemiology-type studies
Artificial intelligence quantitation software harnesses the capabilities of AI and machine learning to process data and produce rapid insights
Waters announces at ASMS 2024 that more than 40 products in its LC chemistry portfolio have obtained certification
Agilent Technologies, Merck, ZEISS, and Waters among those recognized
Dr. Kangxin He at Zhejiang University has developed a high-throughput drug screening platform using patient-derived organoids to identify the best treatment for individual patients